Valerio Therapeutics Société anonyme (ALVIO.PA)
EUR 0.08
(3.31%)
EUR 0.08
(3.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.59 Million | -9.44 Million | -8.57 Million | -4.67 Million | -7.69 Million | -11.26 Million |
| Net Income | -20.34 Million | -19.56 Million | -5.93 Million | 1.08 Million | -33.72 Million | -9.39 Million |
| Depreciation & Amortization | 480 Thousand | -167 Thousand | 511 Thousand | -8.21 Million | 25.39 Million | 9.17 Million |
| Deferred income taxes | 17 Thousand | 285 Thousand | 100 Thousand | 814 Thousand | -2.28 Million | -6.94 Million |
| Stock-based compensation | 514 Thousand | 724 Thousand | 224 Thousand | 79 Thousand | 441 Thousand | 927 Thousand |
| Change in working capital | -665 Thousand | 6.87 Million | -4.13 Million | 886 Thousand | 959 Thousand | -5.54 Million |
| Other non-cash items | 2.89 Million | 2.4 Million | 666 Thousand | 669 Thousand | 1.52 Million | 518 Thousand |
| Investing Cash Flow | -177 Thousand | -409 Thousand | -66 Thousand | 6.01 Million | 137 Thousand | 1000.00 |
| Investments in PPE | -183 Thousand | -488 Thousand | -139 Thousand | -119 Thousand | -26 Thousand | -45 Thousand |
| Acquisitions | - | - | - | 14 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 7000.00 | 80 Thousand | 73 Thousand | 4000.00 | 163 Thousand | - |
| Other Investing Activities | -1000.00 | -1000.00 | 73 Thousand | 6.11 Million | 163 Thousand | 46 Thousand |
| Financing Cash Flow | 10.75 Million | 6.46 Million | 11.97 Million | 7.48 Million | 2.01 Million | 8.25 Million |
| Debt repayment | -1.22 Million | -1.51 Million | -3.1 Million | -3.09 Million | -2.72 Million | -193 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -125 Thousand | - | - | - | - | -150 Thousand |
| Common Stock Issuance | 12.11 Million | 7.97 Million | 9.35 Million | 10.57 Million | 5.19 Million | 2.74 Million |
| Other Financing Activities | -7000.00 | 2000.00 | 5.73 Million | -1000.00 | -452 Thousand | 8.44 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -665 Thousand | 6.87 Million | -4.13 Million | 886 Thousand | 959 Thousand | -5.54 Million |
| Cash at beginning of period | 14.58 Million | 17.88 Million | 14.52 Million | 5.7 Million | 11.25 Million | 14.27 Million |
| Cash at end of period | 6.81 Million | 14.58 Million | 17.88 Million | 14.52 Million | 5.7 Million | 11.25 Million |
| Capital Expenditure | -183 Thousand | -488 Thousand | -139 Thousand | -119 Thousand | -26 Thousand | -45 Thousand |
| Effect of forex changes on cash | 244 Thousand | 87 Thousand | 25 Thousand | -3000.00 | 3000.00 | -8000.00 |
| Net cash flow / Change in cash | -7.76 Million | -3.3 Million | 3.36 Million | 8.81 Million | -5.54 Million | -3.02 Million |
| Free Cash Flow | -18.78 Million | -9.93 Million | -8.71 Million | -4.79 Million | -7.72 Million | -11.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.47 Million | -5.47 Million | -20.34 Million | -4.35 Million | -4.35 Million | -11.64 Million |
| Depreciation & Amortization | 840 Thousand | 840 Thousand | 480 Thousand | 176 Thousand | 176 Thousand | 125 Thousand |
| Deferred income taxes | - | - | 17 Thousand | 17 Thousand | - | -385 Thousand |
| Stock-based compensation | 97.5 Thousand | 97.5 Thousand | 514 Thousand | 122 Thousand | 122 Thousand | 135 Thousand |
| Change in working capital | 1.07 Million | 1.07 Million | -665 Thousand | -1.37 Million | -1.37 Million | 2.08 Million |
| Other non-cash items | 50.5 Thousand | 50.5 Thousand | 2.89 Million | 689.5 Thousand | 689.5 Thousand | 562 Thousand |
| Investing Cash Flow | -18 Thousand | -18 Thousand | -177 Thousand | -40 Thousand | -40 Thousand | -97 Thousand |
| Investments in PPE | -20 Thousand | -20 Thousand | -183 Thousand | -43 Thousand | -43 Thousand | -97 Thousand |
| Acquisitions | 4000.00 | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 7000.00 | 7000.00 | - | - |
| Other Investing Activities | 2000.00 | 2000.00 | -1000.00 | 3000.00 | 3000.00 | - |
| Financing Cash Flow | 2.09 Million | 2.09 Million | 10.75 Million | -342 Thousand | -342 Thousand | 11.44 Million |
| Debt repayment | -4.36 Million | - | -1.22 Million | -503 Thousand | - | -384 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -125 Thousand | -62.5 Thousand | -62.5 Thousand | - |
| Common Stock Issuance | - | - | 12.11 Million | 114 Thousand | - | 12 Million |
| Other Financing Activities | 2.09 Million | 2.09 Million | -7000.00 | -279.5 Thousand | -279.5 Thousand | -7000.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.07 Million | 1.07 Million | -665 Thousand | -1.37 Million | -1.37 Million | 1.04 Million |
| Cash at beginning of period | 6.81 Million | - | 14.58 Million | 16.82 Million | - | 14.58 Million |
| Cash at end of period | 4 Million | -1.41 Million | 6.81 Million | 6.81 Million | -5 Million | 16.82 Million |
| Capital Expenditure | -20 Thousand | -20 Thousand | -183 Thousand | -43 Thousand | -43 Thousand | -97 Thousand |
| Effect of forex changes on cash | -77 Thousand | -77 Thousand | 244 Thousand | 116 Thousand | 116 Thousand | 6000.00 |
| Net cash flow / Change in cash | -2.81 Million | -1.41 Million | -7.76 Million | -10 Million | -5 Million | 2.24 Million |
| Free Cash Flow | -3.43 Million | -3.43 Million | -18.78 Million | -4.78 Million | -4.78 Million | -9.21 Million |
9220
JMPLY
6805
601788
ROI
BAJFINANCE